Back to News

UMDF Power Surge 2020 – online event

The mitochondrial medicine community came together virtually for the Power Surge 2020 online event. This event is organized by the United Mitochondrial Disease Foundation (UMDF). Speakers and presenters provided thought-provoking discussions surrounding clinical trials, current topics facing the patient community in today’s unprecedented landscape. Dr Magali Taiel, Chief Medical Officer, is invited to give an oral presentation  on LUMEVOQ® during the session “Clinical Trial Updates” on Friday 26 June, 2020.
  • Title:  LUMEVOQ®, Gene Therapy in Leber Hereditary Optic Neuropathy (LHON)
  • Session:  Clinical Trial Updates
  • Date:  Friday, June 26, 2020
Back to News

A New Chapter

Founded in 2012 to realize the potential of gene therapy, GenSight Biologics has grown into a clinical-stage company advancing multiple programs. In 2024, under a new management team, the company entered a new phase and is now accelerating its clinical and regulatory activities.

Explore investors’ hub

GenSight Biologics S.A.
74 rue du Faubourg Saint-Antoine
75012 Paris
France